Judith Balmana

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 191 publications

Surgical Management of Early-Onset Breast Cancer Among Young BRCA1 and BRCA2 Carriers.

Surgical Management of Early-Onset Breast Cancer Among Young BRCA1 and BRCA2 Carriers.

Journal: JAMA network open

Published: August 26, 2026

Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer.

Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 16, 2026

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.

Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 25, 2026

RNA splicing evidence enables robust classification of BRCA1 exon 18 variants: Results from the ENIGMA consortium.

RNA splicing evidence enables robust classification of BRCA1 exon 18 variants: Results from the ENIGMA consortium.

Journal: American journal of human genetics

Published: February 19, 2026

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Journal: Frontiers in oncology

Published: February 10, 2026

Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.

Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 08, 2026

Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.

Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 08, 2026

Comprehensive clinical cancer analysis of homologous recombination deficiency biomarkers in an academic molecular profiling program.

Comprehensive clinical cancer analysis of homologous recombination deficiency biomarkers in an academic molecular profiling program.

Journal: NPJ precision oncology

Published: January 23, 2026

Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer.

Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer.

Journal: ESMO open

Published: December 17, 2025

Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors.

Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors.

Journal: ESMO open

Published: September 01, 2025

Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 08, 2025

Optimising rare tumour risk syndromes care: clinical insights and the PREVENTABLE socioeconomic framework.

Optimising rare tumour risk syndromes care: clinical insights and the PREVENTABLE socioeconomic framework.

Journal: European journal of human genetics : EJHG

Published: June 23, 2025

Showing 1-12 of 191

Last Updated: 09/26/2026